07:00 , Jun 20, 2016 |  BC Week In Review  |  Financial News

Mersana completes venture financing

Mersana Therapeutics Inc. , Cambridge, Mass.   Business: Cancer   Date completed: 2016-06-16   Type: Venture financing   Raised: $33 million   Investors: Wellington Management; Cormorant Asset Management; Arrowpoint Partners; Takeda Pharmaceutical Co. Ltd. ;...
00:32 , Jun 17, 2016 |  BC Extra  |  Financial News

Mersana raises $33M in series C round

Antibody-drug conjugate (ADC) developer Mersana Therapeutics Inc. (Cambridge, Mass.) raised $33 million in a series C round led by new investor Wellington Management Company. Also participating were new investors Cormorant Asset Management, Arrowpoint Partners and...
07:00 , Sep 7, 2015 |  BC Week In Review  |  Financial News

Syndax completes venture financing

Syndax Pharmaceuticals Inc. , Waltham, Mass.   Business: Cancer   Date completed: 2015-08-24   Type: Venture financing   Raised: $80 million   Investors: Fidelity; Delos Capital; EcoR1 Capital; OrbiMed Advisors; Jennison Associates; Tavistock Life Sciences;...
01:53 , Aug 25, 2015 |  BC Extra  |  Financial News

Syndax raises $80M in series C

Syndax Pharmaceuticals Inc. (Waltham, Mass.) raised $80 million in a series C round led by Fidelity and Delos Capital. EcoR1 Capital, OrbiMed, Jennison Associates, Tavistock Life Sciences, Arrowpoint Partners, Cormorant Asset Management, BioMed Ventures and...